Humacyte, Inc. (HUMA) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| DCF Value (model) | $-7.22 |
| DCF Upside vs Price | -1120.5% |
| Altman Z-Score | -7.97 (distress) |
| Sector P/E (Healthcare) | 21.7 |
HUMA overview · HUMA earnings · HUMA KPIs · HUMA investor relations · HUMA ownership · HUMA peers · HUMA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.